AlphaFold predicted structure
GFAP · P14136

Mean pLDDT
80.0/ 100
Confident
432 residues
Confidence breakdown
- Very high(≥ 90)58%
- Confident(70–90)15%
- Low(50–70)7%
- Very low(< 50)19%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glial fibrillary acidic protein
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Adult onset dystonia, chorea or related movement disorder
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownAdult onset leukodystrophy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownAdult onset neurodegenerative disorder
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownAtaxia and cerebellar anomalies - narrow panel
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownHereditary ataxia
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown+7 more panels — install the extension to see the full list inline on any page.
Alexander disease
hereditary disease
Alexander disease type I
Seizure
Alexander disease type II
spastic paraplegia, intellectual disability, nystagmus, and obesity
metachromatic leukodystrophy
Progressive ventriculomegaly
scoliosis
Abnormality of the skeletal system
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Glial fibrillary acidic protein
GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells
GFAP · P14136

Mean pLDDT
80.0/ 100
Confident
432 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0